Briefing: Is It Too Late To Reassess USA Rare Earth (USAR) After Recent Share Price Pullback?
Strategic angle: An analysis of USA Rare Earth's recent share price decline and its implications for investors.
Strategic angle: An analysis of USA Rare Earth's recent share price decline and its implications for investors.
Strategic angle: The White House is readying a 100% tax on some imported medicines, a draft order shows.
Strategic angle: Indian equities plunged as the Iran war triggered a record wave of foreign investor sell‑offs. Experts warn the downturn may not be over yet.
Strategic angle: MarketWatch reports on the decline in stock futures amid geopolitical tensions.
Strategic angle: GLC production heads to Alabama to join GLE and GLS as tariffs reshape luxury car strategy
Strategic angle: A viral video claims Israeli Jews are reclaiming land in Morocco, but the evidence is misleading.
Strategic angle: The market's worst days are often followed by the best days, according to JPMorgan Asset Management data. Investors who stay the course stand to gain the most.
Strategic angle: Nike warned that its turnaround is taking longer than it expected, leading three Wall Street banks to downgrade the stock as investors lose patience.
Strategic angle: Dayton Webber, the quadruple amputee cornhole player who is facing murder charges, will continue to be held without bond as his case moves forward, a Maryland judge ruled.
Strategic angle: Analyzing the future potential of Nu Holdings stock over the next decade.
Strategic angle: Mushrooms communicate through underground networks, sharing secrets and information with their neighbors.
Strategic angle: Pinterest's stock experiences a decline due to a weaker than expected outlook.
Strategic angle: The Dow sees gains amid political developments while Nike's earnings report causes a significant drop.
Market rebounds as investors anticipate resolution in the ongoing conflict.
Strategic angle: Investors in the S&P 500 Index face significant losses as market conditions worsen.
Strategic angle: Stocks rebound significantly as we review the key events of Q1.
Strategic angle: Here is STAT’s biotech scorecard, our regular ledger of stock-moving biotech events, for the second quarter.
Strategic angle: The casting news we’ve all been waiting for has finally dropped, and the reveal of Daniel Craig's successor as 007 may surprise some James Bond fans.
Strategic angle: Richard Gould attributes recent player criticism to their own exclusion from the team.
Strategic angle: Yields on China’s debt are down marginally since the start of the conflict while those of other major economies have risen.